Boots to Be Sold to Weston Family for $9 bn: Canadian Cash in on British Pharmacy

A pharmacy chain with more shelves than a Canadian grocery store is about to get a Canadian makeover, and the price tag is as large as a double‑decker bus.

The private‑equity owner of Boots, the nation’s favourite high‑street pharmacy, is closing in on a sale to the Canadian branch of the Weston family, the same dynasty that sold Selfridges in 2022 for £4 bn.

At a valuation of $9 bn, the deal would be the Westons’ most expensive purchase since they acquired the Canadian supermarket chain Loblaw last decade, and it would restore a familiar family name to UK retail after a brief exile.

Analysts say the sale is a reminder that Canadian capital is still itching for a taste of the British market, even if it means filling a pharmacy aisle with fresh maple syrup‑flavoured cough drops.

Regulators in the UK and Canada will need to decide whether this cross‑Atlantic transaction will require a prescription for approval, and whether the new owners will keep the same loyalty program or swap it for a maple‑leaf‑badge.

If the deal closes, the Westons will be able to claim they own the most frequent prescription of Canadian dollars in the UK – a headline that will be hard to beat at the next cross‑border trade fair.